FIELD: medicine.
SUBSTANCE: device for collection and stabilization of blood or a component thereof comprises the first end and the second end, and at least one inner wall forming a reservoir. At that, the reservoir includes a stabilizing agent containing a lysophospholipase (LysoPLA) inhibitor and an anticoagulant. Also a method for collection and stabilization of blood or a component thereof, a method for metabolism disorders diagnosis, a method for detection of presence of a prodrug and/or its active metabolites in blood or blood component, a method for treatment monitoring of patients with metabolic disorders, and a method for determination of the prodrug and/or its active metabolite amount in blood or blood component, are disclosed.
EFFECT: inventions group provides relatively long-term stability of blood or a component thereof during storage for a reliable clinical test.
21 cl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF 9-AMINOACRIDINE OR THEIR SALTS WITH ORGANIC OR INORGANIC ACIDS SHOWING PSYCHOTROPIC, ANTIAMNESTIC AND LIPID-REGULATING ACTIVITY | 1991 |
|
RU2024509C1 |
METHOD OF REDUCTION OF CARBONYL-CONTAINING ACRIDINE DERIVATIVE OR ITS PHARMACEUTICALLY ACCEPTABLE ACID-ADDITIVE SALT | 1991 |
|
RU2069659C1 |
TETRAHYDROACRIDINE DERIVATIVES, PROCESSES FOR PREPARATION THEREOF (VARIANTS), TETRAHYDROACRIDINONE DERIVATIVES, DIHYDROBENZOXAROLE DERIVATIVE AND PHARMACEUTIC COMPOSITION HAVING EFFECT OF EASING OR ELIMINATING MEMORY DYSFUNCTION | 1992 |
|
RU2083564C1 |
4-AMINOPYRIDINE DERIVATIVES | 1992 |
|
RU2039058C1 |
MULTIFUNCTIONAL CONJUGATES OF TACRINE AND ITS ANALOGUES WITH DERIVATIVES OF 1,2,4-TIADIAZOLE, THE WAY OF THEIR SYNTHESIS AND APPLICATION FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | 2017 |
|
RU2675794C1 |
APPLICATION OF ADAMANTANE INDOLE AND THEIR HYDROCHLORIDES AS CHOLINESTERASE INHIBITORS AND NMDA-RECEPTORS BLOCKERS | 2016 |
|
RU2621348C1 |
TACRINE DERIVATIVES AS ACETYLCHOLINESTERASE INHIBITORS | 2004 |
|
RU2402545C2 |
HCV-ACTIVE 4'-ASIDONUCLEOSIDES | 2011 |
|
RU2556991C2 |
USE OF INVERSE AGONISTS OR ANTAGONISTS OF GHRELIN RECEPTOR FOR TREATING SLEEP DISORDERS | 2013 |
|
RU2600895C2 |
NUCLEOTIDES INCLUDING N-[(S)-1-CYCLOBUTOXYCARBONYL]PHOSPHORAMIDATE FRAGMENT, THEIR ANALOGS AND THEIR APPLICATION | 2017 |
|
RU2659388C1 |
Authors
Dates
2017-06-21—Published
2012-03-02—Filed